Tag Archives: TRIUMPH-2

Laboratory scientist conducting peptide research for a 2026 retatrutide Phase 3 clinical study article

30 Sep

Retatrutide Phase 3 Results 2026: What Canadians Should Know

New TRIUMPH-2 Phase 3 data show substantial weight loss and A1C reductions with retatrutide. Here is what Canadians should know about the results, current trials, and regulatory status.